Valeant, Ackman Unveil Sweetened $50B Allergan Bid
Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman on Wednesday boosted their cash-and-stock bid for Botox maker Allergan Inc. to nearly $50 billion, ramping up pressure on the reluctant target...To view the full article, register now.
Already a subscriber? Click here to view full article